European Journal of Drug Metabolism and Pharmacokinetics View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1975

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/13318

Recent publications latest 20 shown

  • 2022-09-19 Development and Validation of a Length- and Habitus-Based Method of Ideal and Lean Body Weight Estimation for Adults Requiring Urgent Weight-Based Medical Intervention
  • 2022-09-15 Metabolic Profiling of Glabridin in Rat Plasma, Urine, Bile, and Feces After Intragastric and Intravenous Administration
  • 2022-09-03 Pharmacokinetics of Oral Rebaudioside A in Patients with Type 2 Diabetes Mellitus and Its Effects on Glucose Homeostasis: A Placebo-Controlled Crossover Trial
  • 2022-08-29 Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment
  • 2022-08-27 Results From Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3
  • 2022-08-19 Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology
  • 2022-08-17 Dual Inhibition of CYP3A4 by Voriconazole and Clarithromycin Influences Tacrolimus Pharmacokinetics: Case Series Study
  • 2022-08-16 Combined Semi-mechanistic Target-Mediated Drug Disposition and Pharmacokinetic–Pharmacodynamic Models of Alirocumab, PCSK9, and Low-Density Lipoprotein Cholesterol in a Pooled Analysis of Randomized Phase I/II/III Studies
  • 2022-08-09 Tigecycline Soft Tissue Penetration in Obese and Non-obese Surgical Patients Determined by Using In Vivo Microdialysis
  • 2022-08-01 Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?
  • 2022-07-26 Nonclinical Pharmacokinetic Evaluation of Desidustat: a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia
  • 2022-07-18 Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer
  • 2022-07-15 Physiologically-Based Pharmacokinetic Models of CYP2D6 Substrate and Inhibitors Nebivolol, Cinacalcet and Mirabegron to Simulate Drug–Drug Interactions
  • 2022-07-15 Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation
  • 2022-07-08 External Validation of a Vancomycin Population Pharmacokinetic Model and Developing a New Dosage Regimen in Neonates
  • 2022-07-06 Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives
  • 2022-07-05 A pH/Time/Pectinase-Dependent Oral Colon-Targeted System Containing Isoliquiritigenin: Pharmacokinetics and Colon Targeting Evaluation in Mice
  • 2022-06-28 Drug Dosing in Critically Ill Adult Patients with Augmented Renal Clearance
  • 2022-06-27 Effect of Nonadherence on Levetiracetam Pharmacokinetics and Remedial Dose Recommendations Using Monte Carlo Simulations
  • 2022-06-25 Pharmacokinetic Comparison of Nine Bioactive Compounds of Guanxinshutong Capsule in Normal and Acute Myocardial Infarction Rats
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.7120000123977661", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.5299999713897705", 
            "type": "Rating"
          }
        ], 
        "description": "

    Announcement
    \nEuropean Journal of Drug Metabolism and Pharmacokinetics invites submission of Original Research, Practical Application, Current Opinion and Review Articles on the topics of preclinical and clinical pharmacokinetics and pharmacodynamics.
    \nSubmit Now!

    \n\n

    European Journal of Drug Metabolism and Pharmacokinetics promotes drug development by providing researchers essential information on preclinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy.

    \n\n

    As a hybrid journal, European Journal of Drug Metabolism and Pharmacokinetics does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

    \n\n

    European Journal of Drug Metabolism and Pharmacokinetics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

    \n", "editor": [ { "familyName": "Singh", "givenName": "Jasbir", "type": "Person" } ], "id": "sg:journal.1085481", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0378-7966", "2107-0180" ], "license": "Hybrid", "name": "European Journal of Drug Metabolism and Pharmacokinetics", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "85481" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "7608491" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "440426" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14932" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1085481" ], "sdDataset": "journals", "sdDatePublished": "2022-10-01T07:03", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1975", "type": "Periodical", "url": "https://link.springer.com/journal/13318" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1085481'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1085481'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1085481'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1085481'


     

    This table displays all metadata directly associated to this object as RDF triples.

    56 TRIPLES      20 PREDICATES      26 URIs      22 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1085481 schema:contentRating N555343766f0e42c4ab0ae2c176b0d9d4
    2 Nf86dcc848f314d9ab8c5bfb618301af2
    3 schema:description <p>Announcement<br /> <em>European Journal of Drug Metabolism and Pharmacokinetics</em> invites submission of Original Research, Practical Application, Current Opinion and Review Articles on the topics of preclinical and clinical pharmacokinetics and pharmacodynamics.<br /> Submit Now!</p> <p><em>European Journal of Drug Metabolism and Pharmacokinetics </em>promotes drug development by providing researchers essential information on preclinical and clinical pharmacokinetics &amp; pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy.</p> <p>As a hybrid journal, <em>European Journal of Drug Metabolism and Pharmacokinetics&nbsp;</em>does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice&trade; initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the &lsquo;How to publish with us, including Open Access&rsquo; link below.</p> <p><em>European Journal of Drug Metabolism and Pharmacokinetics </em>offers a range of additional features designed to increase the visibility, readership and educational value of the journal&rsquo;s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager&reg;, supported by a database of international experts. This database is shared with other Adis journals.</p>
    4 schema:editor N55735159d1b24d93b52ab2aeadc18a6a
    5 schema:inLanguage en
    6 schema:isAccessibleForFree false
    7 schema:issn 0378-7966
    8 2107-0180
    9 schema:license Hybrid
    10 schema:name European Journal of Drug Metabolism and Pharmacokinetics
    11 schema:productId N0b5887c545fc4a3ba338321edfa2da11
    12 N3ff44abf60b64e9b889fc48ceefc689e
    13 Nc8eec4d71a4b48639f0931cdef2eabd9
    14 Nf182f361898c4982a2201834229e7f2c
    15 schema:publisher N70bcd8757cab463792f6f2462b54d006
    16 schema:publisherImprint Adis
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1085481
    18 schema:sdDatePublished 2022-10-01T07:03
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher Nd4784ea3af71405f9c8e0c2070a78a0c
    21 schema:startYear 1975
    22 schema:url https://link.springer.com/journal/13318
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset journals
    25 rdf:type schema:Periodical
    26 N0b5887c545fc4a3ba338321edfa2da11 schema:name dimensions_id
    27 schema:value 85481
    28 rdf:type schema:PropertyValue
    29 N3ff44abf60b64e9b889fc48ceefc689e schema:name nsd_ids_id
    30 schema:value 440426
    31 rdf:type schema:PropertyValue
    32 N555343766f0e42c4ab0ae2c176b0d9d4 schema:author Na5a8e36de3cd419eaedab81ad8f2a637
    33 schema:ratingValue 0.7120000123977661
    34 rdf:type schema:Rating
    35 N55735159d1b24d93b52ab2aeadc18a6a rdf:first Nfdacba4fcca444ba863aeda9dd357974
    36 rdf:rest rdf:nil
    37 N70bcd8757cab463792f6f2462b54d006 schema:name Springer International Publishing
    38 rdf:type schema:Organization
    39 N88a0e690495c4ca3bd1aa4136f21601c rdf:first sjr
    40 rdf:rest rdf:nil
    41 Na5a8e36de3cd419eaedab81ad8f2a637 rdf:first snip
    42 rdf:rest rdf:nil
    43 Nc8eec4d71a4b48639f0931cdef2eabd9 schema:name nlm_unique_id
    44 schema:value 7608491
    45 rdf:type schema:PropertyValue
    46 Nd4784ea3af71405f9c8e0c2070a78a0c schema:name Springer Nature - SN SciGraph project
    47 rdf:type schema:Organization
    48 Nf182f361898c4982a2201834229e7f2c schema:name era_ids_id
    49 schema:value 14932
    50 rdf:type schema:PropertyValue
    51 Nf86dcc848f314d9ab8c5bfb618301af2 schema:author N88a0e690495c4ca3bd1aa4136f21601c
    52 schema:ratingValue 0.5299999713897705
    53 rdf:type schema:Rating
    54 Nfdacba4fcca444ba863aeda9dd357974 schema:familyName Singh
    55 schema:givenName Jasbir
    56 rdf:type schema:Person
     




    Preview window. Press ESC to close (or click here)


    ...